PTEN and acute lymphoblastic leukemia: The potential of a dual inhibitor to lower disease burden and prolong survival in mice and the fact that dual inhibitors limit proliferation and enhance proapoptotic pathways in human tumors further demonstrate the dependence of PTEN null mutation T-ALL on the combined activities of PI3Kgamma/delta.